Prudent Man Advisors LLC Has $1.41 Million Stock Holdings in Axon Enterprise, Inc $AXON

Prudent Man Advisors LLC lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 31.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,708 shares of the biotechnology company’s stock after purchasing an additional 410 shares during the quarter. Prudent Man Advisors LLC’s holdings in Axon Enterprise were worth $1,414,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. CVA Family Office LLC boosted its position in Axon Enterprise by 26.9% during the 2nd quarter. CVA Family Office LLC now owns 66 shares of the biotechnology company’s stock worth $55,000 after acquiring an additional 14 shares during the last quarter. LaSalle St. Investment Advisors LLC boosted its position in Axon Enterprise by 2.1% during the 1st quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock worth $408,000 after acquiring an additional 16 shares during the last quarter. Hemington Wealth Management boosted its position in Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 17 shares during the last quarter. Washington Trust Advisors Inc. boosted its position in Axon Enterprise by 44.7% during the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock worth $46,000 after acquiring an additional 17 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in Axon Enterprise by 5.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock worth $203,000 after acquiring an additional 18 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 2.7%

AXON opened at $735.95 on Friday. Axon Enterprise, Inc has a 1-year low of $422.38 and a 1-year high of $885.91. The stock’s fifty day simple moving average is $733.17 and its 200 day simple moving average is $725.28. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock has a market cap of $57.77 billion, a PE ratio of 181.72, a price-to-earnings-growth ratio of 28.58 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter in the prior year, the business earned $1.20 EPS. The firm’s revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insiders Place Their Bets

In related news, CAO Jennifer H. Mak sold 77 shares of the stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares in the company, valued at approximately $11,402,280. This represents a 0.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the sale, the chief executive officer owned 3,033,982 shares in the company, valued at approximately $2,165,474,312.68. This trade represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 59,932 shares of company stock worth $45,115,616 in the last quarter. Company insiders own 4.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AXON. Northland Securities set a $800.00 price target on Axon Enterprise in a research report on Tuesday, August 5th. Wolfe Research began coverage on Axon Enterprise in a research report on Monday, July 7th. They set an “outperform” rating for the company. Piper Sandler began coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price objective on the stock. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Finally, JPMorgan Chase & Co. upped their price objective on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.